Trademark: 90807548
Status Date
Wednesday, November 1, 2023
Filing Date
Thursday, July 1, 2021
Published for Opposition
Tuesday, April 26, 2022
5 Pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
Nov 3, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 1, 2023
Sou Extension 3 Granted
Nov 1, 2023
Sou Extension 3 Filed
Nov 1, 2023
Sou Teas Extension Received
May 10, 2023
Notice Of Approval Of Extension Request E-Mailed
May 8, 2023
Sou Extension 2 Granted
May 8, 2023
Sou Extension 2 Filed
May 8, 2023
Sou Teas Extension Received
Dec 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Dec 8, 2022
Teas Change Of Correspondence Received
Dec 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 8, 2022
Teas Change Of Owner Address Received
Nov 4, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 2, 2022
Sou Extension 1 Granted
Nov 2, 2022
Sou Extension 1 Filed
Nov 2, 2022
Sou Teas Extension Received
Jun 21, 2022
Noa E-Mailed - Sou Required From Applicant
Apr 26, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 26, 2022
Published For Opposition
Apr 6, 2022
Notification Of Notice Of Publication E-Mailed
Mar 24, 2022
Approved For Pub - Principal Register
Mar 22, 2022
Assigned To Examiner
Sep 13, 2021
New Application Office Supplied Data Entered
Jul 5, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
